Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 28, 2011
Complaint involves Guidant's conduct leading to its recalls of ICDs in 2005, before Boston Scientific’s 2006 acquisition of Guidant
-
Jan 27, 2011
Procedure performed as part of BLOCk-CTI clinical trial evaluating treatment of Type 1 atrial flutter
-
Jan 26, 2011
PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent
-
Jan 24, 2011
Fourth-generation stent features bioabsorbable polymer and everolimus drug coating
-
Jan 19, 2011
Distribution agreement will allow Company to expand the service it offers customers in Japan
-
Jan 19, 2011
A live webcast and archived replay of this call will be available
-
Jan 19, 2011
Innovative left atrial appendage closure device offers alternative for patients with atrial fibrillation and strengthens Company's position in emerging structural heart markets
-
Jan 10, 2011
ORION clinical trial designed to evaluate EPIC™ Self-Expanding Nitinol Stent System for the treatment of iliac artery disease
-
Jan 5, 2011Innovative technology designed to advance deep brain stimulation therapy
Boston Scientific Corporation (NYSE: BSX) today announced it has acquired Intelect Medical, Inc., a development-stage company located in...
-
Jan 4, 2011
Article reported on a study that found about 20 percent of patients who received an implantable cardioverter defibrillator (ICD) did not meet evidence-based guidelines
-
Jan 4, 2011
Acquisition brings Boston Scientific the first fully repositionable device for percutaneous aortic valve replacement to treat severe aortic stenosis
-
Jan 3, 2011
Company prepays $600 million of debt
-
Dec 27, 2010
Company will participate in the conference on January 11, 2011. A live webcast and replay will be available.
-
Dec 20, 2010
Distinguished leader brings broad range of expertise in science, technology, business, education and government
-
Dec 7, 2010
Patients experienced a 50 percent relative reduction in risk of death compared to in-clinic follow-up
-
Nov 22, 2010
Company will participate in the conference on December 1, 2010. A live webcast and replay will be available.
-
Nov 19, 2010
Innovative percutaneous aortic valve replacement system provides entry into emerging market of structural heart disease
-
Nov 19, 2010
INCEPTA™, ENERGEN™ and PUNCTUA™ designed to advance patient care with options to expand appropriate therapy, optimize ventricular pacing and manage heart failure
-
Nov 17, 2010
Awards recognize breakthrough products and technologies that represent a significant leap forward in their respective categories
-
Nov 11, 2010
Company supports efforts of International Diabetes Federation to promote worldwide diabetes education and prevention
-
Nov 10, 2010
Company's November 19, 2010 meeting will be simultaneously webcast; learn how to tune in live or access the replay.
-
Nov 9, 2010
Company implants its first Deep Brain Stimulation device designed to treat Parkinson's
-
Nov 2, 2010Two-year data presented at CHEST 2010 demonstrate ability of FDA-approved, non-drug asthma treatment to provide long-lasting symptom control
Boston Scientific Corporation (NYSE: BSX) today announced that its newly acquired subsidiary, Asthmatx, Inc., presented two-year...
-
Oct 28, 2010
Proceeds to allow Company to invest in future growth opportunities while also reducing overall debt leverage
-
Oct 26, 2010
Acquisition brings the Alair® Bronchial Thermoplasty System, the first device-based asthma treatment approved by the FDA